Treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL)

Leukemia

Volumn 11, Issue SUPPL. 4, 1997, Pages

  Weiss, Mark A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Acute leukemia; ALL; Chemotherapy; Refractory; Relapsed

Indexed keywords

ANTHRACYCLINE; ANTHRAQUINONE; CYTARABINE; IDARUBICIN; MITOXANTRONE; PREDNISONE; RAZOXANE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; LEUKEMIA REMISSION; PRIORITY JOURNAL;

EID: 0030940747     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Larson RA, Dodge RK, Burns CP, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and leukemia group B study 8811. /ooc/1995; 85:2025-2037.
2. Kantarjian HM, Walters RS, Keating MJ, et al. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. / Clin Oncol 1990; 8: 994-1004.
3. Linker CA, Levitt LJ, O'Donnell M, et al. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: A follow-up report. Blood 1991 ; 78:2814-2822.